Exploring the RNA-Recognition Mechanism Using Supervised Molecular Dynamics (SuMD) Simulations: Toward a Rational...

Area of Science:

• Computational chemistry
• Structural biology
• Drug discovery

Background:

• Proteins have historically been primary drug targets, but RNA's pharmaceutical importance is increasing.
• Advances in structural biology reveal complex 3D RNA structures amenable to small molecule or peptide modulation.
• Computational methods like molecular docking face challenges with RNA's flexibility, charge distribution, and solvent interactions.

Purpose of the Study:

• To validate and expand the use of the SuMD (all-atoms molecular dynamics) protocol for RNA targets.
• To accelerate the sampling of molecular recognition events involving RNA on a nanosecond timescale.
• To assess SuMD's accuracy in predicting binding modes for pharmaceutically relevant RNA complexes.

Main Methods:

• Utilized SuMD, an all-atoms molecular dynamics protocol designed to accelerate molecular recognition.
• Applied the protocol to various ribonucleic acid targets of pharmaceutical interest.
• Validated the method by reproducing known binding modes of viral, prokaryotic, and engineered RNA complexes.

Main Results:

• SuMD successfully reproduced the binding modes of diverse ribonucleic acid complexes with high accuracy.
• The protocol demonstrated effectiveness in sampling molecular recognition events on a nanosecond timescale.
• The validated SuMD protocol shows promise for rational drug design targeting RNA.

Conclusions:

• The SuMD protocol is a validated and effective computational tool for studying RNA-small molecule interactions.
• This methodology can accelerate the discovery and development of novel RNA-binding drug candidates.
• SuMD offers a powerful approach to overcome computational challenges in targeting RNA.